IRIS
MADEDDU, Giordano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.028
AS - Asia 6.592
EU - Europa 5.632
SA - Sud America 4.408
AF - Africa 285
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 26
AN - Antartide 1
Totale 33.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.736
BR - Brasile 3.978
SG - Singapore 3.152
IT - Italia 2.336
CN - Cina 1.606
UA - Ucraina 1.020
DE - Germania 666
HK - Hong Kong 590
FI - Finlandia 297
VN - Vietnam 284
GB - Regno Unito 230
FR - Francia 201
SE - Svezia 201
AR - Argentina 155
RU - Federazione Russa 128
CA - Canada 122
TR - Turchia 122
NL - Olanda 105
IN - India 100
IQ - Iraq 100
MX - Messico 100
BD - Bangladesh 95
ZA - Sudafrica 86
EC - Ecuador 82
PL - Polonia 66
MA - Marocco 62
UZ - Uzbekistan 61
PK - Pakistan 60
CZ - Repubblica Ceca 59
JP - Giappone 55
ES - Italia 54
VE - Venezuela 53
RO - Romania 45
CO - Colombia 41
BE - Belgio 39
AE - Emirati Arabi Uniti 38
KR - Corea 38
NP - Nepal 38
TN - Tunisia 34
ID - Indonesia 31
AT - Austria 30
PY - Paraguay 30
KE - Kenya 28
AU - Australia 25
AZ - Azerbaigian 23
JO - Giordania 23
RS - Serbia 22
UY - Uruguay 22
KZ - Kazakistan 21
IL - Israele 20
LT - Lituania 19
PE - Perù 19
SA - Arabia Saudita 19
IE - Irlanda 18
KG - Kirghizistan 17
CL - Cile 16
DO - Repubblica Dominicana 16
EU - Europa 14
IR - Iran 14
OM - Oman 14
AL - Albania 13
CH - Svizzera 13
DZ - Algeria 13
JM - Giamaica 13
EG - Egitto 12
BG - Bulgaria 11
PA - Panama 11
PS - Palestinian Territory 11
SN - Senegal 11
PH - Filippine 10
CR - Costa Rica 9
HU - Ungheria 9
LB - Libano 9
BO - Bolivia 8
XK - ???statistics.table.value.countryCode.XK??? 8
AM - Armenia 7
MD - Moldavia 7
MY - Malesia 7
BY - Bielorussia 6
GR - Grecia 6
HN - Honduras 6
MK - Macedonia 6
NG - Nigeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BN - Brunei Darussalam 5
ET - Etiopia 5
LU - Lussemburgo 5
PT - Portogallo 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
CI - Costa d'Avorio 3
GT - Guatemala 3
KW - Kuwait 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BH - Bahrain 2
Totale 32.951
Salva come PNG Salva come JPEG
Città #
Dallas 9.376
Singapore 1.800
Chandler 1.265
Hong Kong 588
Jacksonville 579
Beijing 406
Princeton 396
Ashburn 387
New York 316
São Paulo 259
Rome 221
Munich 198
Nanjing 194
Dearborn 190
Los Angeles 171
Wilmington 155
Sassari 151
Shanghai 151
Milan 148
Helsinki 128
Rio de Janeiro 128
Boardman 121
Belo Horizonte 112
Ann Arbor 106
Ho Chi Minh City 96
Santa Clara 94
Columbus 90
Nanchang 82
The Dalles 81
Brasília 74
Curitiba 70
Shenyang 70
Hanoi 63
Naples 60
Campinas 59
Tianjin 58
Brno 56
Porto Alegre 56
Warsaw 54
Tashkent 51
Tokyo 48
Cagliari 47
Council Bluffs 47
Woodbridge 47
Florence 45
Changsha 43
Hebei 43
Johannesburg 42
Montreal 42
Denver 41
Brooklyn 40
San Francisco 40
Brussels 39
Fortaleza 39
Salvador 39
London 38
Guarulhos 37
Buffalo 36
Nuremberg 36
Baghdad 35
Jinan 35
Toronto 35
Orem 34
Palermo 34
Seoul 34
Guayaquil 32
São José dos Campos 32
Atlanta 31
Poplar 31
Frankfurt am Main 30
Goiânia 30
São Bernardo do Campo 30
Turku 30
Zhengzhou 30
Guangzhou 29
San Jose 29
Houston 28
Jiaxing 27
Phoenix 27
Santo André 27
Sorocaba 27
Chennai 26
Ningbo 26
Recife 26
Ribeirão Preto 26
Turin 26
Nairobi 25
Norwalk 25
Stockholm 25
Amsterdam 24
Bologna 24
Campo Grande 24
Dhaka 24
Istanbul 24
Andover 23
Izmir 23
Lahore 23
Amman 22
Baku 22
Boston 22
Totale 20.586
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.783
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 823
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 639
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 628
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 561
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 519
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 514
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study 416
PARVOVIRUS B19 E POLIMIALGIA REUMATICA: THE BUTTERFLY EFFECT 303
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 272
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 261
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 257
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics) 253
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 252
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 247
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 245
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 242
Fluoroquinolones and Biofilm: A Narrative Review 224
Efficacy and tolerability of antiretroviral therapy: focus on people with HIV or on PrEP 218
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV 212
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 199
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 197
99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation 195
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 195
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 191
A case of vasculitis-like skin eruption associated with COVID-19 186
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 185
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 184
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 175
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 171
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 170
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 169
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 167
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 158
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 158
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 157
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 157
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 156
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 154
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. 154
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 154
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 152
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 148
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 147
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 147
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 144
Adverse skin reactions in course of combined antiretroviral therapy 143
Meningite linfomatosa in un paziente con linfoma plasmoblastico del cavo orale HIV-relato: ruolo della citarabina liposomiale. 141
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 141
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 138
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 138
Trends in the European HIV/AIDS epidemic: a perspective from Italy 137
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 136
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 135
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 134
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 134
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 134
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 131
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 131
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 131
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 130
Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors 129
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 129
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 129
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 129
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 129
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 127
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 127
Kidney disease in HIV-infected patients. 126
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 125
Cytological and histological diagnosis of lung cancer in Sardinia and Italy in the 1990s 125
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 125
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 125
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 125
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 124
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 124
Bacterial community-acquired pneumonia in HIV-infected patients 124
Utilizzo di EVG/COBI/FTC/TDF in una paziente con viremia elevata e cirrosi HCV-correlata 123
Hepatic echinococcosis: clinical and therapeutic aspects. 121
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 121
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 119
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 119
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. 118
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 117
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 117
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 115
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 115
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 114
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 114
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 114
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 113
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 113
Infectious diseases screening approach among refugees: Results from a single-center study 113
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 112
QuantiFERON TB Gold: a new method for latent tuberculosis infection 112
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 112
The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients 112
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 112
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 111
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 111
Totale 19.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021913 0 0 0 0 0 67 187 52 271 224 76 36
2021/20221.109 130 29 26 26 26 32 40 63 83 72 143 439
2022/20232.522 239 209 68 414 208 404 37 274 402 47 130 90
2023/20241.209 139 72 56 40 293 114 35 79 17 48 101 215
2024/20259.092 150 144 492 308 492 405 674 1.560 2.882 1.231 517 237
2025/202614.921 655 3.112 7.385 1.796 1.431 542 0 0 0 0 0 0
Totale 33.542